Effect of adrenergic agonists and antagonists on renin release.
Michael
R
R
Brookdale University Hospital and Medical Center, New York, NY 11212, USA.
Fam
F
F
Abadir
A
A
D000322:Adrenergic Agonists / Q000494:pharmacology*; D018674:Adrenergic Antagonists / Q000494:pharmacology*; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007511:Ischemia / Q000378:metabolism; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects; D012083:Renin / Q000378:metabolism*
D000322:Adrenergic Agonists; D018674:Adrenergic Antagonists; D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010656:Phenylephrine; D011433:Propranolol; D012083:Renin; D004837:Epinephrine; D010646:Phentolamine